Eris Lifesciences acquires 51% in Swiss Parenterals for Rs 637 crore
This deal also marks the entry of Eris into the RoW Export Markets.
Source: moneycontrol.com
Stay updated with breaking news from Row Export. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This deal also marks the entry of Eris into the RoW Export Markets.